These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 24001743

  • 1. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S, Restituto P, Monreal I, Colina I, Calleja A, Varo N.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [Abstract] [Full Text] [Related]

  • 2. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR, Reid IR, Resch H, Siris E, Uebelhart D, Wang A, Weryha G, Cummings SR.
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [Abstract] [Full Text] [Related]

  • 3. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
    Smilic TN, Novakovic TR, Markovic-Jovanovic SR, Smilic LLJ, Mitic JS, Radunovic ML.
    J Clin Densitom; 2018 Mar; 21(3):322-328. PubMed ID: 29103946
    [Abstract] [Full Text] [Related]

  • 4. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, Zhang ZL.
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [Abstract] [Full Text] [Related]

  • 5. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Xu L.
    Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
    [Abstract] [Full Text] [Related]

  • 6. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.
    Mederle OA, Balas M, Ioanoviciu SD, Gurban CV, Tudor A, Borza C.
    Clin Interv Aging; 2018 Nov; 13():1383-1389. PubMed ID: 30122910
    [Abstract] [Full Text] [Related]

  • 7. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
    Anastasilakis AD, Polyzos SA, Efstathiadou ZA, Savvidis M, Sakellariou GT, Papatheodorou A, Kokkoris P, Makras P.
    Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
    [Abstract] [Full Text] [Related]

  • 8. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
    Costa AG, Walker MD, Zhang CA, Cremers S, Dworakowski E, McMahon DJ, Liu G, Bilezikian JP.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4736-43. PubMed ID: 24037879
    [Abstract] [Full Text] [Related]

  • 9. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
    Hannon R, Blumsohn A, Naylor K, Eastell R.
    J Bone Miner Res; 1998 Jul; 13(7):1124-33. PubMed ID: 9661076
    [Abstract] [Full Text] [Related]

  • 10. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 11. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y, Haifa H, Datel O, Fadoua HN, Smeh BH, Mahbouba J, Saoussen Z, Bejia I, Mongi T, Mohamed FN, Naceur B.
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [Abstract] [Full Text] [Related]

  • 12. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I.
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [Abstract] [Full Text] [Related]

  • 13. Thalassemic osteopathy: a new marker of bone deposition.
    Baldini M, Forti S, Orsatti A, Marcon A, Ulivieri FM, Airaghi L, Zanaboni L, Cappellini MD.
    Blood Cells Mol Dis; 2014 Aug; 52(2-3):91-4. PubMed ID: 24091145
    [Abstract] [Full Text] [Related]

  • 14. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
    Xu XJ, Shen L, Yang YP, Lu FR, Zhu R, Shuai B, Li CG, Wu MX.
    Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
    [Abstract] [Full Text] [Related]

  • 15. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF, Geyikli I, Yazgan P, Celik A.
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [Abstract] [Full Text] [Related]

  • 16. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
    Jiajue R, Jiang Y, Qi X, Wang Q, Wang W, Pei Y, Wang X, Huang W, Zheng X, Ning Z, Wang O, Li M, Xing X, Yu W, Xu L, Xia W.
    Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
    [Abstract] [Full Text] [Related]

  • 17. Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
    Qin YJ, Zhang ZL, Zhang H, Hu WW, Liu YJ, Hu YQ, Li M, Gu JM, He JW.
    Acta Pharmacol Sin; 2008 Dec; 29(12):1493-8. PubMed ID: 19026169
    [Abstract] [Full Text] [Related]

  • 18. Determinants of bone turnover markers in healthy premenopausal women.
    Adami S, Bianchi G, Brandi ML, Giannini S, Ortolani S, DiMunno O, Frediani B, Rossini M, BONTURNO study group.
    Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
    [Abstract] [Full Text] [Related]

  • 19. Correlation of plasma microRNA-21 expression and bone turnover markers in postmenopausal women.
    Perksanusak T, Panyakhamlerd K, Hirankarn N, Suwan A, Vasuratna A, Taechakraichana N.
    Climacteric; 2018 Dec; 21(6):581-585. PubMed ID: 30232913
    [Abstract] [Full Text] [Related]

  • 20. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A, Hannon RA, Eastell R.
    J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.